Virtu Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Virtu Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,920	Closed	-$82K	–	2336
2021 Q1	$82K	Buy	+19,920	New	+$86.3K	0.01%	1368
2019 Q4	$122K	Sell	25,975 -13,945	-35%	-$57.1K	0.01%	1047
2019 Q3	$134K	Sell	39,920 -102,687	-72%	-$338K	0.01%	1040
2019 Q2	$469K	Buy	+142,607	New	+$413K	0.03%	560
2019 Q1	–	Sell	-16,601	Closed	-$45K	–	2025
2018 Q4	$45K	Buy	+16,601	New	+$54.7K	﹤0.01%	1279
2018 Q3	–	Sell	-15,151	Closed	-$39K	–	2411
2018 Q2	$39K	Buy	+15,151	New	+$37.7K	﹤0.01%	1800
2018 Q1	–	Sell	-58,575	Closed	-$117K	–	2838
2017 Q4	$117K	Buy	+58,575	New	+$127K	0.01%	1864

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Virtu Financial's ATRS Position: Q2 2021 in Review

Virtu Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 19,920 shares — an estimated $82K sold.

Virtu Financial first reported a position in ATRS in Q4 2017 and held it in 7 quarters. The position peaked at $469K in Q2 2019. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

Virtu Financial reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
Virtu Financial sold 19,920 Antares Pharma, Inc. shares in Q2 2021, an estimated $82K.
Virtu Financial first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 7 quarters.
Virtu Financial's Antares Pharma, Inc. position peaked at $469K in Q2 2019.
175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Virtu Financial's 13F filing for Q2 2021, filed 17 Sep 2021.